Strides Pharma Science Share Price
Small Cap | Pharmaceuticals and health care | NSE: STAR | BSE: 532531
₹652.45 15.65 (2.46 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 627.50
High (₹) 654.75
Low (₹) 616.55
Prev. Close (₹) 636.80
Volume 39,351
VWAP (₹) 642.53
ROCE (%) 18.99
Industry P/E 43.99
TTM P/E 22.31
P/B Ratio 2.89
Market Cap (₹) Cr.6,008.09
Dividend Yield (%)0.38
EPS (₹) -7.76
ROE-3.44%
Sales Growth (%) 9.83
Profit Growth (%)11.61
Day Range
654.75654.75
52 Week Range
530.701,675.25
Historical Returns
Returns (6M)
-50.46 %
Returns (1Y)
-19.1 %
Returns (3Y)
87.67 %
Returns (5Y)
32.58 %
Returns (6M)
-50.46 %
Returns (1Y)
-19.1 %
Returns (3Y)
87.67 %
Returns (5Y)
32.58 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 48.06
MFI 61.41
ATR 45.91
Commodity Channel Index -39.96
ROC125 -49.94
ROC21 7.64
Williams %R -57.00
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 666.35 | 679.65 | 704.55 | 641.45 | 628.15 | 603.25 | 589.95 |
Week Ago | 680.14 | 717.47 | 745.04 | 652.57 | 615.24 | 587.67 | 550.34 |
Month Ago | 600.04 | 629.77 | 645.94 | 583.87 | 554.14 | 537.97 | 508.24 |
EMA & SMA
652.45
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
15
5 Day 628.72
9 Day 657.66
10 Day 671.54
12 Day 685.29
14 Day 678.66
20 Day 658.19
26 Day 647.74
50 Day 664.09
100 Day 1063.66
200 Day 1060.81
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
SHASUN LEASING & FINANCE PVT LTD | block | Sell | 09 Feb, 2024 | ₹713.00 | 3,35,672 | BSE |
BAJAJ FINANCE LIMITED | block | Sell | 09 Feb, 2024 | ₹713.00 | 5,63,829 | BSE |
AMANSA HOLDING PRIVATE LTD. | block | Buy | 09 Feb, 2024 | ₹713.00 | 5,63,829 | BSE |
BAJAJ FINANCE LIMITED | bulk | Sell | 09 Feb, 2024 | ₹713.00 | 8,04,629 | BSE |
AMANSA HOLDING PRIVATE LTD. | bulk | Buy | 09 Feb, 2024 | ₹713.00 | 11,40,301 | BSE |
AMANSA HOLDING PRIVATE LTD. | bulk | Buy | 02 Jan, 2024 | ₹659.81 | 12,23,200 | BSE |
SHASUN ENTERPRISES LLP | block | Sell | 29 Dec, 2023 | ₹637.00 | 2,50,000 | BSE |
PACE STOCK BROKING SERVICES PVT LTD | block | Buy | 29 Dec, 2023 | ₹637.00 | 2,50,000 | BSE |
PRONOMZ VENTURES LLP | block | Sell | 06 Nov, 2023 | ₹470.00 | 9,49,000 | BSE |
BNP PARIBAS ARBITRAGE | block | Buy | 06 Nov, 2023 | ₹470.00 | 9,49,000 | BSE |
PRONOMZ VENTURES LLP | bulk | Sell | 06 Nov, 2023 | ₹470.00 | 9,49,000 | BSE |
BNP PARIBAS ARBITRAGE | bulk | Buy | 06 Nov, 2023 | ₹470.00 | 9,49,000 | BSE |
CAPRI GLOBAL HOLDINGS PRIVATE LIMITED | bulk | Sell | 06 Oct, 2023 | ₹500.53 | 12,00,000 | BSE |
SMALLCAP WORLD FUND INC | bulk | Buy | 12 Apr, 2021 | ₹849.99 | 5,96,895 | BSE |
APAX GLOBAL ALPHA LIMITED | bulk | Sell | 29 Jan, 2020 | ₹445.00 | 9,54,092 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
25 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹350.6842024202420242024202420 | 45,450 | BSE |
24 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹330.0818233082706766917293233 | 53,200 | BSE |
17 Mar, 2022 | AGRAGANYA PRIVATE TRUST | Acquisition | ₹323.4190166666666666666666667 | 3,00,000 | BSE |
15 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹320.7896274678111587982832618 | 2,91,250 | BSE |
04 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹318.0204615384615384615384615 | 52,000 | BSE |
28 Feb, 2022 | Karuna Business Solutions LLP | Acquisition | ₹327.3064516129032258064516129 | 1,550 | BSE |
28 Feb, 2022 | Arun Kumar | Acquisition | ₹321.5921391752577319587628866 | 1,55,200 | BSE |
28 Sept, 2021 | Amit Kumar Himmatsinghka | Disposal | ₹639.7592307692307692307692308 | 2,600 | BSE |
24 Sept, 2021 | Sandeep Baid | Disposal | ₹628.85025 | 4,000 | BSE |
22 Sept, 2021 | Aravinda R | Disposal | ₹602.30 | 2,500 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
22 May, 2024 | Rs.2.5000 per share(25%)Final Dividend | 09 Sept, 2024 | 09 Sept, 2024 |
21 Jul, 2023 | Rs.1.5000 per share(15%)Final Dividend | 04 Aug, 2023 | 04 Aug, 2023 |
27 May, 2021 | Rs.2.5000 per share(25%)Final Dividend | 05 Aug, 2021 | 06 Aug, 2021 |
Announcements
Date | Source | Detail |
---|---|---|
18 Feb, 2025 | NSE India | Strides Pharma Science Limited has submitted to the Exchange Copy of Newspaper advertisement made regarding dispatch of Postal Ballot Notice dated January 30, 2025. |
17 Feb, 2025 | NSE India | STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot |
17 Feb, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange regarding Notice of Postal Ballot |
17 Feb, 2025 | BSE India | Intimation on launch of Postal Ballot |
04 Feb, 2025 | BSE India | Transcript of Earnings Call pertaining to Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2024. |
04 Feb, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange about Transcript |
31 Jan, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange about Copy of Newspaper Publication of unaudited financial results for the quarter and nine months ended December 31, 2024. |
30 Jan, 2025 | BSE India | Audio Recording of Earnings call pertaining to the Un-Audited Financial Results for the quarter and nine months ended December 31, 2024 |
30 Jan, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange about Link of Recording |
30 Jan, 2025 | NSE India | STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 25 Jan, 2025 | 30 Jan, 2025 |
Quarterly Results | -- | 21 Oct, 2024 | 24 Oct, 2024 |
Quarterly Results | -- | 23 Jul, 2024 | 29 Jul, 2024 |
Audited Results & Final Dividend | -- | 15 May, 2024 | 22 May, 2024 |
Quarterly Results | -- | 24 Jan, 2024 | 30 Jan, 2024 |
Quarterly Results | -- | 23 Oct, 2023 | 30 Oct, 2023 |
Scheme of Arrangement | -- | 21 Sept, 2023 | 25 Sept, 2023 |
Quarterly Results | -- | 27 Jul, 2023 | 02 Aug, 2023 |
Audited Results & Final Dividend | -- | 19 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 18 Jan, 2023 | 24 Jan, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Strides Pharma Science
Strides Pharma Science is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2153.26 Cr. and Equity Capital is Rs. 91.90 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Strides Group
Founded
1990
Managing Director
Mr. Badree Komandur
NSE Symbol
STAR
Strides Pharma Science Management
Name | Designation |
---|---|
Mr. Arun Kumar | Executive Chairperson |
Mr. Badree Komandur | Managing Director & Group CEO |
Mr. Aditya Kumar | Executive Director |
Dr. Kausalya Santhanam | Independent Director |
Mr. Homi Rustam Khusrokhan | Independent Director |
Mr. Ameet Hariani | Independent Director |
Mr. Subir Chakraborty | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Strides Pharma Science
What is the share price of Strides Pharma Science?
The share price of Strides Pharma Science on 21 Feb, 2025 is ₹ 652.45.
What is 52W high and 52W low share price of Strides Pharma Science?
The highest and lowest 52W share prices of Strides Pharma Science are ₹ 1675.250 and ₹ 634.100
What is the market cap of Strides Pharma Science?
The market capitalization of Strides Pharma Science as of 21 Feb, 2025 is ₹ 6,008.09 Crores
What is the P/E ratio of Strides Pharma Science?
The current P/E ratio of Strides Pharma Science as of 21 Feb, 2025 is 43.99
What is the PB ratio of Strides Pharma Science?
The PB ratio of Strides Pharma Science as of 21 Feb, 2025 is 2.89
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)